
TY  - JOUR
AU  - Pendergrast, Jacob
AU  - Armali, Chantal
AU  - Cserti-Gazdewich, Christine
AU  - Hansen, Mark
AU  - Kiss, Alex
AU  - Lieberman, Lani
AU  - Parmar, Nagina
AU  - Scales, Damon
AU  - Skeate, Robert
AU  - Callum, Jeannie
AU  - Lin, Yulia
TI  - Can furosemide prevent transfusion-associated circulatory overload? Results of a pilot, double-blind, randomized controlled trial
JO  - Transfusion
JA  - Transfusion
VL  - 59
IS  - 6
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.15270
DO  - doi:10.1111/trf.15270
SP  - 1997
EP  - 2006
PY  - 2019
AB  - BACKGROUND Transfusion-associated circulatory overload (TACO) is a leading cause of transfusion-attributable morbidity. It is unclear whether diuretics are safe and effective in preventing this reaction. MATERIALS AND METHODS In a pilot controlled feasibility trial, inpatients 65?years or older ordered a single unit of red blood cells were randomized to pre-transfusion furosemide 20?mg or placebo intravenously. Primary outcome was the ability to enroll 80 patients within a 2-month time period. Secondary feasibility outcomes included proportion of RBC transfusions meeting eligibility criteria, proportion of eligible patients enrolled, and compliance to study protocol. Clinical outcomes included the incidence of TACO and associated complications. RESULTS Nine months of enrollment were required for 80 patients to complete the study, due primarily to fewer transfusions than expected meeting eligibility criteria and lower than anticipated consent rates. Protocol compliance was below target due to missing chart documentation of patient fluid balance, and transfusion infusion time. Blinding was maintained throughout the study and treatment arms were well-balanced. A single case of TACO occurred in each arm, for an overall incidence of 2.5%. No differences in peri-transfusion vital signs, B-natriuretic peptide, or signs of furosemide toxicity were observed. CONCLUSION The study protocol was not feasible as designed, primarily due to challenges in patient enrollment. Modifications to trial design to improve feasibility in future studies have been identified.
ER  - 

TY  - JOUR
TI  - 2014 Annual Meeting of the American Society for Bone and Mineral Research Houston, TX September 12–15, 2014
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 29
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2476
DO  - doi:10.1002/jbmr.2476
SP  - S1
EP  - S1
PY  - 2014
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 165
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.12802
DO  - doi:10.1111/bjh.12802
SP  - 1
EP  - 103
PY  - 2014
ER  - 

TY  - JOUR
AU  - Hall, H. Roe Bartle
TI  - ACCP 1999 Annual Meeting Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 19
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.19.15.1191.30577
DO  - doi:10.1592/phco.19.15.1191.30577
SP  - 1191
EP  - 1240
PY  - 1999
ER  - 

TY  - JOUR
TI  - THSNA 2018 Summit Abstract Proceedings
JO  - American Journal of Hematology
JA  - Am J Hematol
VL  - 93
IS  - 9
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.25268
DO  - doi:10.1002/ajh.25268
SP  - E253
EP  - E328
PY  - 2018
ER  - 

TY  - JOUR
TI  - Focus Group
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13513
DO  - doi:10.1111/tri.13513
SP  - 127
EP  - 158
PY  - 2019
ER  - 

TY  - JOUR
TI  - Third Annual Sickle Cell Disease Research and Educational Symposium and Grant Writing Institute and Annual National Sickle Cell Disease Scientific Meeting
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 84
IS  - 8
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21445
DO  - doi:10.1002/ajh.21445
SP  - E1
EP  - E235
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 69
IS  - s3
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.12766
DO  - doi:10.1111/anae.12766
SP  - 13
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
TI  - CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_6.x
DO  - doi:10.1111/j.1479-8077.2006.00199_6.x
SP  - A39
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - CYTOKINES AND INFLAMMATORY MEDIATORS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_7.x
DO  - doi:10.1111/j.1479-8077.2006.00199_7.x
SP  - A39
EP  - A45
PY  - 2006
ER  - 

TY  - JOUR
TI  - Recent advances in transplantation anesthesia and intensive care medicine
JO  - Acta Anaesthesiologica Scandinavica
VL  - 41
IS  - s111
SN  - 0001-5172
UR  - https://doi.org/10.1111/j.1399-6576.1997.tb04887.x
DO  - doi:10.1111/j.1399-6576.1997.tb04887.x
SP  - 77
EP  - 84
PY  - 1997
ER  - 

TY  - JOUR
TI  - The following abstracts were presented at the 16th Annual Scientific Congress of the British Society of Orthopaedic Anaesthetists in London, November 2011
JO  - Anaesthesia
VL  - 67
IS  - 6
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.2012.07082.x
DO  - doi:10.1111/j.1365-2044.2012.07082.x
SP  - 684
EP  - 689
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 181
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15226
DO  - doi:10.1111/bjh.15226
SP  - 5
EP  - 211
PY  - 2018
ER  - 

TY  - JOUR
TI  - Concurrent Abstracts Session Two: Tuesday 24th May 0900-1030
JO  - Journal of Paediatrics and Child Health
JA  - Journal of Paediatrics and Child Health
VL  - 52
IS  - S2
SN  - 1034-4810
UR  - https://doi.org/10.1111/jpc.13194_1
DO  - doi:10.1111/jpc.13194_1
SP  - 29
EP  - 55
PY  - 2016
ER  - 

TY  - JOUR
TI  - 2012 Annual Meeting of the American Society for Bone and Mineral Research Minneapolis, MN October 12–15, 2012
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 27
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.1852
DO  - doi:10.1002/jbmr.1852
SP  - S1
EP  - S1
PY  - 2012
AB  - Abstract Searchable abstracts may be found at http://www.asbmr.org/Meetings/PastAnnualMeetings.aspx.
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 63
IS  - S1
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.13439
DO  - doi:10.1111/jgs.13439
SP  - S1
EP  - S320
PY  - 2015
ER  - 

TY  - JOUR
TI  - Paper Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 54
IS  - S4
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2006.00783.x
DO  - doi:10.1111/j.1532-5415.2006.00783.x
SP  - S1
EP  - S203
PY  - 2006
ER  - 

TY  - JOUR
TI  - Full Oral
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13507
DO  - doi:10.1111/tri.13507
SP  - 7
EP  - 126
PY  - 2019
ER  - 

TY  - JOUR
AU  - OGER, E.
AU  - LACUT, K.
AU  - LE GAL, G.
AU  - COUTURAUD, F.
AU  - GUÉNET, D.
AU  - ABALAIN, J.-H.
AU  - ROGUEDAS, A.-M.
AU  - MOTTIER, D.
AU  - THE EDITH COLLABORATIVE STUDY GROUP
TI  - Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case–control study
JO  - Journal of Thrombosis and Haemostasis
VL  - 4
IS  - 4
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2006.01856.x
DO  - doi:10.1111/j.1538-7836.2006.01856.x
SP  - 793
EP  - 799
PY  - 2006
AB  - Summary.? Background:?Moderate hyperhomocysteinemia and B vitamins deficiency are thought to be risk factors for venous thromboembolism (VTE). The causality and independence of those associations are still questioned. Methods:?We measured fasting serum total homocysteine, folates, and vitamin B12 levels as well as 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T genotypes in 467 patients hospitalized with a first well-documented deep vein thrombosis and/or pulmonary embolism not related to a major acquired risk factor and 467 controls matched for gender and age. Results:?Mild hyperhomocysteinemia, low serum folates, and vitamin B12 were associated with VTE independently of each other. In multivariate analysis, odds ratios (OR) (95% CI) for VTE associated with mild hyperhomocysteinemia (>15??mol?L?1), low serum folates (≤?4.9?nmol?L?1), and vitamin B12 (≤?253?pmol?L?1) were 1.48 (1.05?2.08), 3.14 (1.35?7.32) and 1.42 (1.03?1.98), respectively. An MTHFRC677T genotype was not significantly associated with VTE; OR (95% CI): 1.13 (0.70?1.81) Conclusions:?The current data provides further knowledge in the complex relationship between hyperhomocysteinemia, low vitamin levels, and VTE.
ER  - 

TY  - JOUR
AU  - Nagy, G.S.
AU  - Rubin, R.H.
TI  - Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient
JO  - Transplant Infectious Disease
VL  - 3
IS  - 4
SN  - 1398-2273
UR  - https://doi.org/10.1034/j.1399-3062.2001.30406.x
DO  - doi:10.1034/j.1399-3062.2001.30406.x
SP  - 220
EP  - 230
KW  - Mycobacteria avium-intracellulare
KW  - kidney transplant
PY  - 2001
ER  - 
